v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Oct. 31, 2022
Apr. 30, 2022
Current assets:    
Cash and cash equivalents $ 76,962,587 $ 85,400,656
Prepaid expenses and other current assets 256,808 94,172
Total current assets 77,219,395 85,494,828
Other assets:    
Intangibles 3,549,427 3,549,427
Investment in SG Austria 1,572,193 1,572,193
Other assets 7,688 7,688
Total other assets 5,129,308 5,129,308
Total Assets 82,348,703 90,624,136
Current liabilities:    
Accounts payable 861,276 205,361
Accrued expenses 449,855 499,009
Total current liabilities 1,311,131 704,370
Total Liabilities 1,311,131 704,370
Commitments and Contingencies (Notes 7 and 9)
Stockholders' equity:    
Common stock, authorized: 33,333,334 shares, $0.0001 par value; shares issued 21,602,078, shares outstanding 19,526,944 as of October 31, 2022, and 20,721,047 shares issued and outstanding as of April 30, 2022, respectively 2,160 2,072
Additional paid-in capital 201,600,651 201,582,107
Accumulated deficit (115,074,175) (111,648,656)
Treasury stock, at cost, 2,075,134 shares as of October 31, 2022 (5,475,891) 0
Accumulated other comprehensive loss (15,173) (15,757)
Total stockholders' equity 81,037,572 89,919,766
Total Liabilities and Stockholders' Equity $ 82,348,703 $ 90,624,136

Source

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development costs 177,996 135,220 337,269 278,833
Compensation expense 400,420 265,012 728,138 533,897
Director fees 102,335 61,054 155,062 124,213
Legal and professional 1,454,826 284,882 2,351,047 470,630
General and administrative 183,043 258,675 427,712 620,621
Total operating expenses 2,318,620 1,004,843 3,999,228 2,028,194
Loss from operations (2,318,620) (1,004,843) (3,999,228) (2,028,194)
Other expenses:        
Interest income 439,171 25,619 578,673 25,619
Interest expense 0 (42) 0 (509)
Other expense (1,058) (480) (4,964) (2,080)
Total other income 438,113 25,097 573,709 23,030
Net loss $ (1,880,507) $ (979,746) $ (3,425,519) $ (2,005,164)
Basic loss per share $ (0.09) $ (0.06) $ (0.17) $ (0.21)
Diluted loss per share $ (0.09) $ (0.06) $ (0.17) $ (0.21)
Weighted average shares outstanding basic 20,585,451 17,357,830 20,742,383 9,474,568
Weighted average shares outstanding diluted 20,585,451 17,357,830 20,742,383 9,474,568

Source

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended 12 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Apr. 30, 2022
Cash flows from operating activities:      
Net loss $ (3,425,519) $ (2,005,164)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock issued for services 2,278 29,331  
Stock issued for compensation 6,667 22,110  
Stock-based compensation 8,807 34,528  
Change in assets and liabilities:      
Increase in prepaid expenses and other current assets (162,637) (168,666)  
Increase in other assets 0 (316)  
Increase (decrease) in accounts payable 655,916 (15,222)  
Decrease in accrued expenses (49,154) (523,435)  
Net cash used in operating activities (2,963,642) (2,626,834)  
Cash flows from investing activities:      
Net cash provided by (used in) investing activities 0 0  
Cash flows from financing activities:      
Repurchase of common stock (5,475,891) 0  
Proceeds from issuance of pre-funded warrants 0 31,669,027  
Proceeds from sale of common stock, net of issuance costs 0 55,693,022  
Proceeds from warrant exercise 880 0  
Net cash provided (used) in financing activities (5,475,011) 87,362,049  
Effect of currency rate exchange on cash and cash equivalents 584 1,291  
Net increase (decrease) in cash and cash equivalents (8,438,069) 84,736,506  
Cash and cash equivalents at beginning of the period 85,400,656 2,202,106 $ 2,202,106
Cash and cash equivalents at end of the period 76,962,587 86,938,612 $ 85,400,656
Supplemental disclosure of cash flows information:      
Cash paid during the periods for income taxes 0 1,600  
Cash paid during the periods for interest 0 509  
Non-cash equity issuance costs $ 0 $ 34,477,000  

Source